Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,248,453
  • Shares Outstanding, K 51,424
  • Annual Sales, $ 136,190 K
  • Annual Income, $ -105,900 K
  • 60-Month Beta 1.04
  • Price/Sales 23.85
  • Price/Cash Flow N/A
  • Price/Book 12.36
Trade PRCT with:

Options Overview Details

View History
  • Implied Volatility 54.93% ( +3.77%)
  • Historical Volatility 40.29%
  • IV Percentile 24%
  • IV Rank 19.72%
  • IV High 98.32% on 10/30/23
  • IV Low 44.28% on 05/24/24
  • Put/Call Vol Ratio 0.65
  • Today's Volume 206
  • Volume Avg (30-Day) 198
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 9,666
  • Open Int (30-Day) 9,512

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.52
  • Number of Estimates 6
  • High Estimate -0.50
  • Low Estimate -0.55
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.10 +1.72%
on 06/14/24
77.00 -17.96%
on 05/15/24
-2.14 (-3.28%)
since 05/14/24
3-Month
45.56 +38.65%
on 04/04/24
77.00 -17.96%
on 05/15/24
+15.48 (+32.46%)
since 03/14/24
52-Week
24.83 +154.41%
on 10/30/23
77.00 -17.96%
on 05/15/24
+28.45 (+81.94%)
since 06/14/23

Most Recent Stories

More News
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”)...

PRCT : 63.17 (-0.49%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”)...

PRCT : 63.17 (-0.49%)
Why Shares of Procept Biorobotics Were Slumping Thursday

The company released first-quarter earnings on Thursday morning.

PRCT : 63.17 (-0.49%)
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -6.78% and 1.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

PRCT : 63.17 (-0.49%)
TMCI : 6.05 (+0.83%)
TransMedics (TMDX) Expected to Beat Earnings Estimates: Should You Buy?

TransMedics (TMDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TMDX : 142.01 (-0.97%)
PRCT : 63.17 (-0.49%)
Analysts Estimate PROCEPT BioRobotics Corporation (PRCT) to Report a Decline in Earnings: What to Look Out for

PROCEPT BioRobotics Corporation (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRCT : 63.17 (-0.49%)
Intuitive Surgical, Inc. (ISRG) Stock Jumps 4.9%: Will It Continue to Soar?

Intuitive Surgical, Inc. (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...

ISRG : 425.78 (+0.68%)
PRCT : 63.17 (-0.49%)
PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -5.66% and 0.33%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for...

PRCT : 63.17 (-0.49%)
AXDX : 1.3500 (+0.75%)
Integer (ITGR) Beats Q4 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of 5.71% and 1.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ITGR : 116.31 (-0.36%)
PRCT : 63.17 (-0.49%)
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -8.51% and 17.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

PRCT : 63.17 (-0.49%)
SGHT : 6.56 (-3.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 65.09
2nd Resistance Point 64.28
1st Resistance Point 63.72
Last Price 63.17
1st Support Level 62.36
2nd Support Level 61.55
3rd Support Level 60.99

See More

52-Week High 77.00
Last Price 63.17
Fibonacci 61.8% 57.07
Fibonacci 50% 50.92
Fibonacci 38.2% 44.76
52-Week Low 24.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar